Clinical Trial Update: Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring neuroimage PET probes (18F-PM-PBB3 and 18F-florbetapir) for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-PM-PBB3 (null)
• 18F-florbetapir (AV-45) (florbetapir)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN